, a bio/informatics shared resource is still "open for business" - Visit the CDS website


  1. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. Yan J, Parekh VV, Mendez-Fernandez Y, Olivares-Villagómez D, Dragovic S, Hill T, Roopenian DC, Joyce S, Van Kaer L (2006) J Exp Med 203(3): 647-59
    › Primary publication · 16505142 (PubMed) · PMC2118255 (PubMed Central)
  2. Inhibition of antitumor immunity by invariant natural killer T cells in a T-cell lymphoma model in vivo. Renukaradhya GJ, Sriram V, Du W, Gervay-Hague J, Van Kaer L, Brutkiewicz RR (2006) Int J Cancer 118(12): 3045-53
    › Primary publication · 16395717 (PubMed)
  3. Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions. Eger KA, Sundrud MS, Motsinger AA, Tseng M, Van Kaer L, Unutmaz D (2006) PLoS One : e50
    › Primary publication · 17183680 (PubMed) · PMC1762372 (PubMed Central)
  4. Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny. Bezbradica JS, Gordy LE, Stanic AK, Dragovic S, Hill T, Hawiger J, Unutmaz D, Van Kaer L, Joyce S (2006) Immunity 25(3): 487-97
    › Primary publication · 16949316 (PubMed)
  5. CD4+CD25+ Tregs and NKT cells: regulators regulating regulators. La Cava A, Van Kaer L, Fu-Dong-Shi (2006) Trends Immunol 27(7): 322-7
    › Primary publication · 16735139 (PubMed)
  6. Autoreactive T cells mediate NK cell degeneration in autoimmune disease. Liu R, Van Kaer L, La Cava A, Price M, Campagnolo DI, Collins M, Young DA, Vollmer TL, Shi FD (2006) J Immunol 176(9): 5247-54
    › Primary publication · 16621990 (PubMed)
  7. The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice. Singh AK, Yang JQ, Parekh VV, Wei J, Wang CR, Joyce S, Singh RR, Van Kaer L (2005) Eur J Immunol 35(4): 1143-54
    › Primary publication · 15761849 (PubMed) · PMC2291523 (PubMed Central)
  8. Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells. Hashimoto D, Asakura S, Miyake S, Yamamura T, Van Kaer L, Liu C, Tanimoto M, Teshima T (2005) J Immunol 174(1): 551-6
    › Primary publication · 15611282 (PubMed)
  9. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Beilke JN, Kuhl NR, Van Kaer L, Gill RG (2005) Nat Med 11(10): 1059-65
    › Primary publication · 16155578 (PubMed)
  10. Innate immunity: NKT cells in the spotlight. Van Kaer L, Joyce S (2005) Curr Biol 15(11): R429-31
    › Primary publication · 15936267 (PubMed)